- Home
- / Titan Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Titan Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Total Funding
$197.1 M
Revenue
$9.1 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 20.0M | 20.1M | 17.6M | 9.1M | |||
| Cost of goods sold | 1.5M | ||||||
| Gross profit | 20.0M | 20.7M | 17.6M | 7.6M | |||
| Gross profit margin, % | 100.0% | 103.0% | 100.0% | 83.6% | |||
| Operating expense total | 39.7M | 59.2M | 15.6M | 50.4M | 43.9M | 10.5M | 21.7M |
| Depreciation and amortization | 29.0K | 33.0K | 283.0K | 699.0K | 3.2M | 2.3M | 813.0K |
| EBITDA | (39.7M) | (59.2M) | 4.4M | (29.7M) | (43.9M) | 7.1M | (14.0M) |
| EBITDA margin, % | 22.2% | -147.7% | 40.5% | -153.9% | |||
| EBIT | (23.9M) | (59.3M) | (23.0M) | (14.7M) | (42.5M) | 6.5M | (9.0M) |
| EBIT margin, % | -115.0% | -73.0% | 37.0% | -98.7% | |||
| Interest income | 288.0K | 116.0K | 29.0K | 73.0K | 145.0K | 308.0K | 141.0K |
| Interest expense | 2.5M | 1.1M | 125.0K | 148.0K | 221.0K | 11.7M | |
| Pre tax profit | (22.6M) | (41.9M) | (24.2M) | (14.8M) | (42.6M) | 7.0M | (20.5M) |
| Income tax expense | 56.0K | (56.0K) | 24.0K | ||||
| Net Income | (22.6M) | (41.9M) | (24.2M) | (14.9M) | (42.5M) | 7.0M | (20.5M) |